SANTA CLARA, Calif. & HOUSTON--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) and Baylor College of Medicine announced today that Baylor has obtained a non-exclusive, worldwide license to a number of Affymetrix patents covering comparative genomic hybridization (CGH) microarray services in Clinical Laboratory Improvement Amendments (CLIA) environments. Financial details of the license were not disclosed.
